Abstract: The present invention provides novel fused ring heterocycle kinase modulators and methods of using the novel fused ring heterocycle kinase modulators to treat diseases mediated by kinase activity.
Type:
Grant
Filed:
July 27, 2005
Date of Patent:
November 18, 2008
Assignee:
SGX Pharmaceuticals, Inc.
Inventors:
William D. Arnold, Andreas Gosberg, Zhe Li, Ruo W. Steensma, Mark E. Wilson
Abstract: The present invention provides fused ring heterocycles as kinase modulators, pharmaceutical compositions containing these modulators, and methods of using these modulators to treat diseases mediated by kinase activity.
Type:
Application
Filed:
April 10, 2008
Publication date:
October 23, 2008
Applicant:
SGX Pharmaceuticals, Inc.
Inventors:
Chixu Chen, Brian Eastman, Andreas Gosberg, Stefan N. Gradl, Gavin Hirst, Stephanie Hopkins, Khanh Thi Tuong Nguyen, Richard Pracitto, Paul E. Sprengeler, Ruo W. Steensma
Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
Type:
Application
Filed:
February 29, 2008
Publication date:
September 11, 2008
Applicant:
SGX Pharmaceuticals, Inc.
Inventors:
William D. Arnold, Pierre Bounaud, Andreas Gosberg, Zhe Li, Ian McDonald, Ruo W. Steensma, Mark E. Wilson
Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
Type:
Grant
Filed:
February 27, 2006
Date of Patent:
April 22, 2008
Assignee:
SGX Pharmaceuticals, Inc.
Inventors:
William D. Arnold, Pierre Bounaud, Andreas Gosberg, Zhe Li, Ian McDonald, Ruo W. Steensma, Mark E. Wilson
Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
Type:
Grant
Filed:
July 27, 2005
Date of Patent:
April 22, 2008
Assignee:
SGX Pharmaceuticals, Inc.
Inventors:
William D. Arnold, Pierre Bounaud, Andreas Gosberg, Zhe Li, Ian McDonald, Ruo W. Steensma, Mark E. Wilson
Abstract: The present invention provides novel fused ring heterocycle kinase modulators and methods of using the novel fused ring heterocycle kinase modulators to treat diseases mediated by kinase activity.
Type:
Application
Filed:
April 10, 2007
Publication date:
December 13, 2007
Applicant:
SGX Pharmaceuticals, Inc.
Inventors:
William Arnold, Pierre Bounaud, Chixu Chen, Brian Eastman, Andreas Gosberg, Stefan Gradl, Stephanie Hopkins, Zhe Li, Ian McDonald, Paul Sprengeler, Ruo Steensma, Mark Wilson
Abstract: The present invention provides pyrazolothiazole kinase modulators, methods of treating certain disease states, such as cancer, and pharmaceutical composition thereof.
Type:
Application
Filed:
November 16, 2006
Publication date:
July 26, 2007
Applicant:
SGX Pharmaceuticals, Inc.
Inventors:
Pierre-Yves Bounaud, Stephanie Hopkins, Elizabeth Jefferson, Mark Wilson, Melissa Wong, Toufike Kanouni
Abstract: The present invention provides novel pyrimidinyl-thiophene kinase modulators and methods of using the novel pyrimidinyl-thiophene kinase modulators to treat diseases mediated by kinase activity.
Type:
Application
Filed:
November 2, 2006
Publication date:
May 24, 2007
Applicant:
SGX Pharmaceuticals, Inc.
Inventors:
William Arnold, Chixu Chen, Stefan Gradl, Stephanie Hopkins, Ruo Steensma, Masaki Tomimoto, Mark Wilson
Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
Type:
Application
Filed:
February 27, 2006
Publication date:
February 22, 2007
Applicant:
SGX Pharmaceuticals, Inc.
Inventors:
William Arnold, Pierre Bounaud, Andreas Gosberg, Zhe Li, Ian McDonald, Ruo Steensma, Mark Wilson
Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
Type:
Application
Filed:
July 27, 2005
Publication date:
February 9, 2006
Applicant:
SGX Pharmaceuticals, Inc.
Inventors:
William Arnold, Pierre Bounaud, Andreas Gosberg, Zhe Li, Ian McDonald, Ruo Steensma, Mark Wilson